Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-11-25 Sale | 2024-11-27 07:47 am | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 20,680 | $9.01 | $186,327 | 791,793 (Direct) | View |
2024-08-23 Sale | 2024-08-27 5:17 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 20,880 | $9.02 | $188,338 | 812,473 (Direct) | View |
2024-05-23 Sale | 2024-05-28 5:00 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 21,626 | $5.79 | $125,215 | 833,353 (Direct) | View |
2021-04-05 Sale | 2021-04-05 9:30 pm | IVERIC bio Inc. | ISEE | Dugel Pravin EVP, Chief Strategy & Business | 28,301 | $6.34 | $179,428 | 191,699 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-22 Option Award | 2024-02-26 8:07 pm | N/A 2024-02-21 | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin Executive Chairman | 2,137,448 | $0 | 2,137,448 (Direct) | View |
2023-07-11 Disposition | 2023-07-13 1:57 pm | N/A N/A | IVERIC bio Inc. | ISEE | Dugel Pravin President | 1,081,660 | $0 | 0 (Direct) | View |
2023-05-03 Exercise | 2023-05-11 5:15 pm | N/A N/A | IVERIC bio Inc. | ISEE | Dugel Pravin President | 4,312 | $0 | 211,660 (Direct) | View |
2023-04-01 Exercise | 2023-04-04 4:27 pm | N/A N/A | IVERIC bio Inc. | ISEE | Dugel Pravin President | 50,000 | $0 | 248,723 (Direct) | View |
2023-01-02 Exercise | 2023-01-04 6:35 pm | N/A N/A | IVERIC bio Inc. | ISEE | Dugel Pravin President | 12,500 | $0 | 186,223 (Direct) | View |
2022-12-20 Option Award | 2022-12-22 6:55 pm | N/A 2032-12-20 | IVERIC bio Inc. | ISEE | Dugel Pravin President | 210,000 | $0 | 210,000 (Direct) | View |
2022-12-18 Exercise | 2022-12-20 7:00 pm | N/A N/A | IVERIC bio Inc. | ISEE | Dugel Pravin President | 13,750 | $0 | 163,723 (Direct) | View |
2022-11-17 Exercise | 2022-11-21 7:48 pm | N/A 2022-12-29 | IVERIC bio Inc. | ISEE | Dugel Pravin President | 8,474 | $10.03 | 122,473 (Direct) | View |
2022-05-03 Exercise | 2022-05-05 6:02 pm | 2022-05-03 N/A | IVERIC bio Inc. | ISEE | Dugel Pravin President | 4,313 | $0 | 126,936 (Direct) | View |
2022-04-01 Exercise | 2022-04-05 5:46 pm | N/A N/A | IVERIC bio Inc. | ISEE | Dugel Pravin President | 50,000 | $0 | 209,686 (Direct) | View |
2021-12-18 Exercise | 2021-12-21 6:04 pm | N/A N/A | IVERIC bio Inc. | ISEE | Dugel Pravin President | 13,750 | $0 | 100,936 (Direct) | View |
2021-12-16 Option Award | 2021-12-20 4:43 pm | N/A 2031-12-16 | IVERIC bio Inc. | ISEE | Dugel Pravin President | 150,000 | $0 | 150,000 (Direct) | View |
2021-11-11 Exercise | 2021-11-15 4:01 pm | N/A 2022-02-07 | IVERIC bio Inc. | ISEE | Dugel Pravin President | 4,237 | $0 | 45,936 (Direct) | View |
2021-11-11 Exercise | 2021-11-15 4:01 pm | N/A N/A | IVERIC bio Inc. | ISEE | Dugel Pravin President | 4,237 | $1.652 | 45,936 (Direct) | View |
2021-06-30 Option Award | 2021-07-02 5:38 pm | N/A N/A | Aerpio Pharmaceuticals Inc. | ARPO | Dugel Pravin Director | 6,331 | $1.52 | 12,568 (Direct) | View |
2021-05-03 Option Award | 2021-05-04 8:49 pm | N/A 2031-05-02 | IVERIC bio Inc. | ISEE | Dugel Pravin President | 52,250 | $0 | 52,250 (Direct) | View |
2021-04-01 Exercise | 2021-04-05 9:30 pm | N/A N/A | IVERIC bio Inc. | ISEE | Dugel Pravin EVP, Chief Strategy & Business | 70,000 | $0 | 191,699 (Direct) | View |
2021-03-31 Option Award | 2021-04-02 8:30 pm | N/A N/A | Aerpio Pharmaceuticals Inc. | ARPO | Dugel Pravin Director | 6,237 | $1.543 | 6,237 (Direct) | View |
Ownership(A) | 2021-03-29 8:37 pm | 2016-02-08 2022-02-07 | IVERIC bio Inc. | ISEE | Dugel Pravin EVP, Ch. Strategy&Busi. Offr. | 0 | $0 | 12,711 (Direct) | View |
2021-02-01 Option Award | 2021-02-03 9:44 pm | N/A 2031-02-01 | Aerpio Pharmaceuticals Inc. | ARPO | Dugel Pravin Director | 17,857 | $0 | 17,857 (Direct) | View |
2020-12-18 Option Award | 2020-12-22 5:49 pm | N/A 2030-12-17 | IVERIC bio Inc. | ISEE | Dugel Pravin EVP, Chief Strategy & Business | 165,000 | $0 | 165,000 (Direct) | View |
2020-06-24 Option Award | 2020-06-26 4:44 pm | N/A 2030-06-24 | Aerpio Pharmaceuticals Inc. | ARPO | Dugel Pravin Director | 52,144 | $0 | 52,144 (Direct) | View |
Ownership | 2020-06-16 10:12 am | N/A N/A | IVERIC bio Inc. | ISEE | Dugel Pravin EVP, Chief Strategy & Business | 0 | $0 | 520,000 (Direct) | View |